Acetylated H4K16 by MYST1 protects UROtsa cells from arsenic toxicity and is decreased following chronic arsenic exposure

Toxicology and Applied Pharmacology

Volumn 241, Issue 3, 2009, Pages 294-302

  Jo, William Jaime ^a   Ren, Xuefeng ^a   Chu, Feixia ^b   Aleshin, Maria ^a   Wintz, Henri ^a   Burlingame, Alma ^b   Smith, Martyn Thomas ^a   Vulpe, Chris Dillon ^a   Zhang, Luoping ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Arsenic; Bladder cancer; Epigenetics; H4K16; Histone acetylation; RNAi; Yeast

Indexed keywords

ARSENIC; ARSENIC DERIVATIVE; HISTONE 4 LYSINE 16 ACETYLTRANSFERASE; HISTONE ACETYLTRANSFERASE; MONOMETHYLARSONOUS ACID; MYST1 PROTEIN; UNCLASSIFIED DRUG;

ACETYLATION; ARTICLE; BLADDER CARCINOGENESIS; BLADDER EPITHELIUM; CHEMICAL CARCINOGENESIS; CHROMATIN STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; EPIGENETICS; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LONG TERM EXPOSURE; PROTEIN EXPRESSION;

ACETYLATION; ARSENICALS; BLOTTING, WESTERN; CHROMATIN; COLORING AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; GENE SILENCING; HISTONE ACETYLTRANSFERASES; HUMANS; MASS SPECTROMETRY; RETROVIRIDAE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SACCHAROMYCES CEREVISIAE; TETRAZOLIUM SALTS; THIAZOLES; URINARY BLADDER;

EID: 70350616210     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2009.08.027     Document Type: Article

References (47)

1. Avvakumov N., and Cote J. The MYST family of histone acetyltransferases and their intimate links to cancer. Oncogene 26 (2007) 5395-5407
2. Benbrahim-Tallaa L., Waterland R.A., Styblo M., Achanzar W.E., Webber M.M., and Waalkes M.P. Molecular events associated with arsenic-induced malignant transformation of human prostatic epithelial cells: aberrant genomic DNA methylation and K-ras oncogene activation. Toxicol. Appl. Pharmacol. 206 (2005) 288-298
3. Brait M., Begum S., Carvalho A.L., Dasgupta S., Vettore A.L., Czerniak B., Caballero O.L., Westra W.H., Sidransky D., and Hoque M.O. Aberrant promoter methylation of multiple genes during pathogenesis of bladder cancer. Cancer Epidemiol. Biomarkers Prev. 17 (2008) 2786-2794
4. Bredfeldt T.G., Jagadish B., Eblin K.E., Mash E.A., and Gandolfi A.J. Monomethylarsonous acid induces transformation of human bladder cells. Toxicol. Appl. Pharmacol. 216 (2006) 69-79
5. Chai C.Y., Huang Y.C., Hung W.C., Kang W.Y., and Chen W.T. Arsenic salts induced autophagic cell death and hypermethylation of DAPK promoter in SV-40 immortalized human uroepithelial cells. Toxicol. Lett. 173 (2007) 48-56
6. Chalkley R.J., Baker P.R., Huang L., Hansen K.C., Allen N.P., Rexach M., and Burlingame A.L. Comprehensive analysis of a multidimensional liquid chromatography mass spectrometry dataset acquired on a quadrupole selecting, quadrupole collision cell, time-of-flight mass spectrometer: II. New developments in ProteinProspector allow for reliable and comprehensive automatic analysis of large datasets. Mol. Cell Proteomics 4 (2005) 1194-1204
7. Chanda S., Dasgupta U.B., Guhamazumder D., Gupta M., Chaudhuri U., Lahiri S., Das S., Ghosh N., and Chatterjee D. DNA hypermethylation of promoter of gene p53 and p16 in arsenic-exposed people with and without malignancy. Toxicol. Sci. 89 (2006) 431-437
8. Chen H., Liu J., Zhao C.Q., Diwan B.A., Merrick B.A., and Waalkes M.P. Association of c-myc overexpression and hyperproliferation with arsenite-induced malignant transformation. Toxicol. Appl. Pharmacol. 175 (2001) 260-268
9. Chen W.T., Hung W.C., Kang W.Y., Huang Y.C., and Chai C.Y. Urothelial carcinomas arising in arsenic-contaminated areas are associated with hypermethylation of the gene promoter of the death-associated protein kinase. Histopathology 51 (2007) 785-792
10. Chu H.A., and Crawford-Brown D. Inorganic arsenic in drinking water and bladder cancer: a meta-analysis for dose-response assessment. Int. J. Environ. Res. Public Health 4 (2007) 340-341
11. Chu F., Nusinow D.A., Chalkley R.J., Plath K., Panning B., and Burlingame A.L. Mapping post-translational modifications of the histone variant MacroH2A1 using tandem mass spectrometry. Mol. Cell Proteomics 5 (2006) 194-203
12. Danaee H., Nelson H.H., Liber H., Little J.B., and Kelsey K.T. Low dose exposure to sodium arsenite synergistically interacts with UV radiation to induce mutations and alter DNA repair in human cells. Mutagenesis 19 (2004) 143-148
13. Drobna Z., Waters S.B., Devesa V., Harmon A.W., Thomas D.J., and Styblo M. Metabolism and toxicity of arsenic in human urothelial cells expressing rat arsenic (+3 oxidation state)-methyltransferase. Toxicol. Appl. Pharmacol. 207 (2005) 147-159
14. Eblin K.E., Bredfeldt T.G., and Gandolfi A.J. Immortalized human urothelial cells as a model of arsenic-induced bladder cancer. Toxicology 248 (2008) 67-76
15. Fraga M.F., Ballestar E., Villar-Garea A., Boix-Chornet M., Espada J., Schotta G., Bonaldi T., Haydon C., Ropero S., Petrie K., Iyer N.G., Perez-Rosado A., Calvo E., Lopez J.A., Cano A., Calasanz M.J., Colomer D., Piris M.A., Ahn N., Imhof A., Caldas C., Jenuwein T., and Esteller M. Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nat. Genet. 37 (2005) 391-400
16. Gupta A., Guerin-Peyrou T.G., Sharma G.G., Park C., Agarwal M., Ganju R.K., Pandita S., Choi K., Sukumar S., Pandita R.K., Ludwig T., and Pandita T.K. The mammalian ortholog of Drosophila MOF that acetylates histone H4 lysine 16 is essential for embryogenesis and oncogenesis. Mol. Cell. Biol. 28 (2008) 397-409
17. Hernandez-Zavala A., Valenzuela O.L., Matousek T., Drobna Z., Dedina J., Garcia-Vargas G.G., Thomas D.J., Del Razo L.M., and Styblo M. Speciation of arsenic in exfoliated urinary bladder epithelial cells from individuals exposed to arsenic in drinking water. Environ. Health Perspect. 116 (2008) 1656-1660
18. Jemal A., Siegel R., Ward E., Murray T., Xu J., and Thun M.J. Cancer statistics, 2007. CA Cancer J. Clin. 57 (2007) 43-66
19. Jensen T.J., Novak P., Eblin K.E., Gandolfi A.J., and Futscher B.W. Epigenetic remodeling during arsenical-induced malignant transformation. Carcinogenesis 29 (2008) 1500-1508
20. Jensen T.J., Wozniak R.J., Eblin K.E., Wnek S.M., Gandolfi A.J., and Futscher B.W. Epigenetic mediated transcriptional activation of WNT5A participates in arsenical-associated malignant transformation. Toxicol. Appl. Pharmacol. 235 (2009) 39-46
21. III) in yeast. Toxicol Sci (2009) 10.1093/toxsci/kfp1162
22. Kimura A., Umehara T., and Horikoshi M. Chromosomal gradient of histone acetylation established by Sas2p and Sir2p functions as a shield against gene silencing. Nat. Genet. 32 (2002) 370-377
23. Lafon A., Chang C.S., Scott E.M., Jacobson S.J., and Pillus L. MYST opportunities for growth control: yeast genes illuminate human cancer gene functions. Oncogene 26 (2007) 5373-5384
24. Landry J., Sutton A., Tafrov S.T., Heller R.C., Stebbins J., Pillus L., and Sternglanz R. The silencing protein SIR2 and its homologs are NAD-dependent protein deacetylases. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 5807-5811
25. Li J., Gorospe M., Barnes J., and Liu Y. Tumor promoter arsenite stimulates histone H3 phosphoacetylation of proto-oncogenes c-fos and c-jun chromatin in human diploid fibroblasts. J. Biol. Chem. 278 (2003) 13183-13191
26. Marshall G., Ferreccio C., Yuan Y., Bates M.N., Steinmaus C., Selvin S., Liaw J., and Smith A.H. Fifty-year study of lung and bladder cancer mortality in Chile related to arsenic in drinking water. J. Natl. Cancer Inst. 99 (2007) 920-928
27. Marsit C.J., Karagas M.R., Danaee H., Liu M., Andrew A., Schned A., Nelson H.H., and Kelsey K.T. Carcinogen exposure and gene promoter hypermethylation in bladder cancer. Carcinogenesis 27 (2006) 112-116
28. Mass M.J., Tennant A., Roop B.C., Cullen W.R., Styblo M., Thomas D.J., and Kligerman A.D. Methylated trivalent arsenic species are genotoxic. Chem. Res. Toxicol. 14 (2001) 355-361
29. Petrick J.S., Jagadish B., Mash E.A., and Aposhian H.V. Monomethylarsonous acid (MMA(III)) and arsenite: LD(50) in hamsters and in vitro inhibition of pyruvate dehydrogenase. Chem. Res. Toxicol. 14 (2001) 651-656
30. Ramirez T., Brocher J., Stopper H., and Hock R. Sodium arsenite modulates histone acetylation, histone deacetylase activity and HMGN protein dynamics in human cells. Chromosoma (2007)
31. Rea S., Xouri G., and Akhtar A. Males absent on the first (MOF): from flies to humans. Oncogene 26 (2007) 5385-5394
32. Rossman T.G., Uddin A.N., and Burns F.J. Evidence that arsenite acts as a cocarcinogen in skin cancer. Toxicol. Appl. Pharmacol. 198 (2004) 394-404
33. Sens D.A., Park S., Gurel V., Sens M.A., Garrett S.H., and Somji S. Inorganic cadmium- and arsenite-induced malignant transformation of human bladder urothelial cells. Toxicol. Sci. 79 (2004) 56-63
34. Shechter D., Dormann H.L., Allis C.D., and Hake S.B. Extraction, purification and analysis of histones. Nature Protocols 2 (2007) 1445-1457
35. Shia W.J., Osada S., Florens L., Swanson S.K., Washburn M.P., and Workman J.L. Characterization of the yeast trimeric-SAS acetyltransferase complex. J. Biol. Chem. 280 (2005) 11987-11994
36. Shia W.J., Li B., and Workman J.L. SAS-mediated acetylation of histone H4 Lys 16 is required for H2A.Z incorporation at subtelomeric regions in Saccharomyces cerevisiae. Genes Dev. 20 (2006) 2507-2512
37. Shia W.J., Pattenden S.G., and Workman J.L. Histone H4 lysine 16 acetylation breaks the genome's silence. Genome Biol. 7 (2006) 217
38. Shogren-Knaak M., Ishii H., Sun J.M., Pazin M.J., Davie J.R., and Peterson C.L. Histone H4-K16 acetylation controls chromatin structure and protein interactions. Science (New York, NY) 311 (2006) 844-847
39. Smith A.H., Goycolea M., Haque R., and Biggs M.L. Marked increase in bladder and lung cancer mortality in a region of Northern Chile due to arsenic in drinking water. Am. J. Epidemiol. 147 (1998) 660-669
40. Steinmaus C., Yuan Y., Bates M.N., and Smith A.H. Case-control study of bladder cancer and drinking water arsenic in the western United States. Am. J. Epidemiol. 158 (2003) 1193-1201
41. Steinmaus C., Bates M.N., Yuan Y., Kalman D., Atallah R., Rey O.A., Biggs M.L., Hopenhayn C., Moore L.E., Hoang B.K., and Smith A.H. Arsenic methylation and bladder cancer risk in case-control studies in Argentina and the United States. J.Occup. Environ. Med. / Am. Coll. Occup. Environ. Med. 48 (2006) 478-488
42. Suka N., Luo K., and Grunstein M. Sir2p and Sas2p opposingly regulate acetylation of yeast histone H4 lysine16 and spreading of heterochromatin. Nat. Genet. 32 (2002) 378-383
43. Taipale M., Rea S., Richter K., Vilar A., Lichter P., Imhof A., and Akhtar A. hMOF histone acetyltransferase is required for histone H4 lysine 16 acetylation in mammalian cells. Mol. Cell. Biol. 25 (2005) 6798-6810
44. Tchounwou P.B., Patlolla A.K., and Centeno J.A. Carcinogenic and systemic health effects associated with arsenic exposure-a critical review. Toxicol. Pathol. 31 (2003) 575-588
45. Xie Y., Liu J., Benbrahim-Tallaa L., Ward J.M., Logsdon D., Diwan B.A., and Waalkes M.P. Aberrant DNA methylation and gene expression in livers of newborn mice transplacentally exposed to a hepatocarcinogenic dose of inorganic arsenic. Toxicology 236 (2007) 7-15
46. Yuan Y., Marshall G., Ferreccio C., Steinmaus C., Selvin S., Liaw J., Bates M.N., and Smith A.H. Acute myocardial infarction mortality in comparison with lung and bladder cancer mortality in arsenic-exposed region II of Chile from 1950 to 2000. Am. J. Epidemiol. 166 (2007) 1381-1391
47. Zhao C.Q., Young M.R., Diwan B.A., Coogan T.P., and Waalkes M.P. Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 10907-10912